76 related articles for article (PubMed ID: 18413826)
21. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
[TBL] [Abstract][Full Text] [Related]
22. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
Kanehira M; Harada Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
Oncogene; 2007 Sep; 26(44):6448-55. PubMed ID: 17452976
[TBL] [Abstract][Full Text] [Related]
23. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
24. S100A2 induces metastasis in non-small cell lung cancer.
Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis.
Ishikawa K; Miyamoto M; Yoshioka T; Kato T; Kaji M; Ohbuchi T; Hirano S; Itoh T; Dosaka-Akita H; Kondo S
Cancer; 2008 Aug; 113(3):530-41. PubMed ID: 18548529
[TBL] [Abstract][Full Text] [Related]
26. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G
Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177
[TBL] [Abstract][Full Text] [Related]
27. Expression of thymosin beta10 and its role in non-small cell lung cancer.
Gu Y; Wang C; Wang Y; Qiu X; Wang E
Hum Pathol; 2009 Jan; 40(1):117-24. PubMed ID: 18789485
[TBL] [Abstract][Full Text] [Related]
28. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
[TBL] [Abstract][Full Text] [Related]
29. HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma.
Gu ZD; Shen LY; Wang H; Chen XM; Li Y; Ning T; Chen KN
Cancer Res; 2009 Jun; 69(12):4969-73. PubMed ID: 19491265
[TBL] [Abstract][Full Text] [Related]
30. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
31. Regulation and function of the Rhox5 homeobox gene.
Hu Z; MacLean JA; Bhardwaj A; Wilkinson MF
Ann N Y Acad Sci; 2007 Dec; 1120():72-83. PubMed ID: 18184911
[TBL] [Abstract][Full Text] [Related]
32. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
Anagnostou VK; Syrigos KN; Bepler G; Homer RJ; Rimm DL
J Clin Oncol; 2009 Jan; 27(2):271-8. PubMed ID: 19064983
[TBL] [Abstract][Full Text] [Related]
33. Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.
Morini M; Astigiano S; Gitton Y; Emionite L; Mirisola V; Levi G; Barbieri O
BMC Cancer; 2010 Nov; 10():649. PubMed ID: 21108812
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.
Kato T; Hayama S; Yamabuki T; Ishikawa N; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):434-42. PubMed ID: 17255263
[TBL] [Abstract][Full Text] [Related]
35. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.
Xu J; Testa JR
J Biol Chem; 2009 Jul; 284(31):20593-601. PubMed ID: 19497851
[TBL] [Abstract][Full Text] [Related]
36. [Inhibition of the expression of FHL2 by RNA interference].
Wang ZY; Zhou L; Ding LH; Lv QJ; Yang X; Ye QN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1149-51. PubMed ID: 21055355
[TBL] [Abstract][Full Text] [Related]
37. Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer.
Nishino R; Takano A; Oshita H; Ishikawa N; Akiyama H; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Oct; 17(19):6272-86. PubMed ID: 21849417
[TBL] [Abstract][Full Text] [Related]
38. Does homeobox-related "positional" genomic information contribute to implantation of metastatic cancer cells at non-random sites?
Anderson KM; Darweesh M; Jajah A; Tsui P; Guinan P; Rubenstein M
Anticancer Res; 2007; 27(4B):2141-53. PubMed ID: 17695497
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic relevance of overexpressed Nanog gene in early lung cancers.
Nirasawa S; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
Oncol Rep; 2009 Sep; 22(3):587-91. PubMed ID: 19639208
[TBL] [Abstract][Full Text] [Related]
40. Transcription Factor DLX5 As a New Target for Promising Antitumor Agents.
Timakhov RA; Fedichev PO; Vinnik AA; Testa JR; Favorova OO
Acta Naturae; 2011 Jul; 3(3):47-51. PubMed ID: 22649693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
